JPIAMR: Network proposal call; BARDA: DRIVe Accelerator call

Dear All: I trust you are now home after ECCMID in Madrid … it was an excellent meeting. Two new funding opportunities have recently crossed my radar: brief summaries and one key link for each are here with some further details below my signature. 

  • EU JPIAMR funding call: As part of its Virtual Research Institute (VRI) initiative, JPIAMR wants to fund as many as 22 collaborative research networks.
  • US BARDA Funding Opportunity Announcement: Building on the job opportunities recently announced for its DRIVe initiative, BARDA is creating an accelerator network providing technical and business development support services to programs funded by DRIVe.

This is great to see happening! All best wishes, –jr

John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Expert-in-Residence, Wellcome Trust. Follow me on Twitter: @JohnRex_NewAbx. See past newsletters and subscribe for the future:

JPIAMR call for network proposals:

  • JPIAMR seeks to encourage research alignment via establishing a Virtual Research Institute in AMR – a global network connecting research performing organisations, including institutes, centres, and infrastructures.
  • In partnership with ten member countries; Canada, Egypt, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, and the United Kingdom, JPIAMR is launching the 8th joint call for transnational Networks. The total budget of the call is approximately 1.1 million Euro. This Network Call “Building the Foundation of the JPIAMR Virtual Research Institute” aims to identify research community needs and develop ideas to form the foundation for the JPIAMR-VRI
  • Up to 22 Networks will be funded with up to €50 000 each coordinator to connect experts from research performing organisations and establish expertise clusters in the AMR community.
  • The formation of larger, multi-coordinator Networks is possible according to national rules.
  • Deadline for proposals is 4 July 2018.

BARDA DRIVEe Accelerator Network: Funding Opportunity Announcement:

  • BARDA’s newest Division of Research, Innovation and Ventures (DRIVe), will stimulate public-private partnership collaborations that spur innovation and investment in health security products and technologies to repopulate the development pipeline and stimulate the public good of the nation. 
  • A key component of this is the DRIVe Accelerator Network, where accelerators work together to identify promising, innovation and then provide wraparound technical and business development support services to programs funded by DRIVe. 
  • DRIVe Accelerator Network support teams will bring together a network of multiple accelerators, building on their individual strengths and unleash them to work directly with product developers funded by DRIVe.  
  • Product development candidates that graduate from DRIVe with support of the DRIVe Accelerator Network will be better positioned for advanced R&D investment, clinical development, and commercialization. 
  • The deadline for proposals is 17 May 2018.

Upcoming meetings of interest to the AMR community:


17 April 2023: FREE Masterclass from FDA / CARB-X wants you!

Dear All, Two quick items today. First, FDA have announced an Antimicrobial Drugs Advisory Committee on 17 April 2023 (9a-4.30p ET). The committee will “discuss new drug application (NDA) 216974, for sulbactam-durlobactam for injection, submitted by Entasis Therapeutics, Inc. The Applicant’s proposed indication is for the treatment of infections due to Acinetobacter baumannii-calcoaceticus complex including multidrug-resistant and

WHO 2023 Pipeline Update: Share Your Preclinical Antibacterial Projects!

Dear All, As you know, WHO updates their preclinical and clinical pipeline summaries at regular intervals. The most current reviews are summarized on These excellent summaries are invaluable for researchers of all types and are also used to inform policy work. There is now a call to for current information on antibacterial pre-clinical projects. Go here

PASTEUR: Sign a letter to make it happen this year!

Dear All, As all regular readers of this newsletter know, I think that creation of suitable Pull incentives by passage of the PASTEUR Act in the United States is THE key to building a vibrant pipeline of products to address the international problem of AMR. PASTEUR came very close to passage at the end of 2022 …

Scroll to Top